NCT00482976View on ClinicalTrials.gov

Effect of LY333531 on Vascular and Neural Functions

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2003

Study Completion Date

March 31, 2005

Conditions

Diabetes Mellitus

Interventions

DRUG

Ruboxistaurin

DRUG

Placebo

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Boston

All Listed Sponsors

collaborator

Joslin Diabetes Center

OTHER

lead

Chromaderm, Inc.

INDUSTRY

NCT00482976 - Effect of LY333531 on Vascular and Neural Functions | Biotech Hunter | Biotech Hunter